Wellcome Trust

Startups

Mucosis brings in $4M for development of first RSV vaccine

Dutch biotech company, Mucosis, announced on Wednesday that it secured a $4 million fund awarded from the Wellcome Trust foundation. This will go toward clinical trials – a phase I dose-finding and safety study, followed by a novel phase II challenge study to assess the efficacy for its respiratory syncytial virus (RSV) intranasal vaccine called SynGEM. […]

Hospitals

PTC Therapeutics gets $5 million drug development award

PTC Therapeutics has received a $5 million Seeding Drug Discovery award from UK charity Wellcome Trust to support the development of small-molecule drugs to battle life-threatening infections caused by multi-drug-resistant, Gram-negative bacteria. The South Plainfield, New Jersey-based drug development company’s anti-infective program is “currently in lead optimization and advancing toward identifying a development candidate,” according […]